 PE,
intracranial hemorrhage, and death of 0.9% (range, 0%1%), 0.2% (range, 0%-1%), and 0.3% (range, 0%-1%),
respectively.27
There are little comparative data evaluating optimal
thrombolytic agents, doses of lytic agents and concurrent
anticoagulants, and infusion techniques. Streptokinase, although rarely used